Cbc Pathway

Cannabichromene (CBC) is a minor cannabinoid synthesized through the same initial enzymatic pathway as CBD and THC, diverging when CBCA synthase acts on cannabigerolic acid (CBGA). Unlike THC and CBD, CBC remains largely understudied in breeding programs, though lineage records indicate it appears across diverse genetic backgrounds. The CBC biosynthetic route is controlled by the same genetic loci governing cannabinoid ratios, making it relevant to breeders selecting for specific chemotype profiles. CBC typically comprises 0.1–0.3% of total cannabinoids in most cultivars, though some specialized lines bred for minor cannabinoid diversity show elevated levels. Understanding the CBGA-to-CBC conversion helps breeders predict chemotype outcomes when crossing parents with different cannabinoid synthase alleles.

Breeders working on minor cannabinoid profiles monitor CBC pathway expression as part of chemotype selection. Stabilizing CBC-dominant genetics requires tracking CBCA synthase gene expression across generations, relevant to craft breeding focused on full-spectrum or non-intoxicating cannabinoid diversity.